NCT07080372Active, not recruiting
Role of Early API in Accurately Differentiating Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Patients
Role of Early Arterial Phase Imaging in Accurately Differentiating Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Patients
Source: ClinicalTrials.gov · Last updated 23 Jul 2025
Brief summary (registry, in English)
Liver cirrhosis is a common consequence of chronic liver disease, resulting from sustained hepatic injury due to various etiologies. Cirrhosis predisposes individuals to the development of hepatocellular carcinoma (HCC), the most prevalent primary malignancy of the liver. Among cirrhotic patients, distinguishing between hepatocellular carcinoma and dysplastic nodules is crucial for timely diagnosis, treatment planning, and prognostic assessment.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 73 (actual)
- First submitted
- 28 Jun 2025
- Start date
- 17 Mar 2025
- Primary completion date
- 1 Sept 2025
- Lead sponsor
- Superior University
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT07080372
What you commit to
- Study type: Observational
- Participants enrolled: 73
- From 17 Mar 2025 to the primary completion date, 1 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients who are allergic or have a history of allergy to contrast media
Other
- Children less than 5years
- Patients with deranged renal function tests
- Pregnant women
Who the study is looking for
- Patients with abnormal LFTs
- Liver lesions of various sizes
- Patients with chronic liver disease
- Individuals undergoing routine liver screening
- Willing participants who consent to the study
Age in the registry: 5 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Lahore General Hospital Coordinator of this site? Confirm its status | Lahore | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.